Clinical and laboratory features of scleroderma patients with pulmonary hypertension

K. Yamane, H. Ihn, Y. Asano, N. Yazawa, M. Kubo, K. Kikuchi, Y. Soma, K. Tamaki

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)


Objective. Pulmonary hypertension (PH) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH. Methods. A cross-sectional study of 125 Japanese patients with SSc was conducted using Doppler echocardiography, other multiple cardiopulmonary tests, and laboratory examination. Results. PH (systolic pressure >40 mmHg) was diagnosed in 20 patients (16%) by Doppler echocardiography. In the six patients who had secondary pulmonary hypertension (SPH), PH was due to severe pulmonary fibrosis; 14 patients had isolated pulmonary hypertension (IPH). An elevated erythrocyte sedimentation rate (ESR) and increased immunoglobulin G (IgG) were found in a significantly greater proportion of the patients with PH than in those without PH. The incidence of pitting scars/ulcers was significantly greater in the patients with SPH than in those without PH. Conclusion. Elevated ESR and increased IgG were common features of scleroderma patients with PH, and scleroderma patients with SPH were inclined to have pitting scars/ulcers.

Original languageEnglish
Pages (from-to)1269-1271
Number of pages3
Issue number11
Publication statusPublished - 2000
Externally publishedYes


  • Doppler echocardiography
  • Pulmonary hypertension
  • Scleroderma

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)


Dive into the research topics of 'Clinical and laboratory features of scleroderma patients with pulmonary hypertension'. Together they form a unique fingerprint.

Cite this